The Claim
Red wine grape pomace significantly reduced plasma IL-1β levels from 329.4 to 37.37 pg/mL in SR-B1−/−ApoE-R61h/h mice with diet-induced ischemic heart disease, with effects comparable to statin treatment, indicating attenuation of systemic inflammation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice with a genetic form of ischemic heart disease caused by diet, red wine grape pomace lowered levels of the inflammatory marker IL-1β in the blood from 329.4 to 37.37 pg/mL, reducing systemic inflammation to a degree similar to statin drugs.
See the scientific wording
Red wine grape pomace significantly reduced plasma IL-1β levels in SR-B1−/−ApoE-R61h/h mice with diet-induced ischemic heart disease, from 329.4 to 37.37 pg/mL, indicating attenuation of systemic inflammation, with effects comparable to statin treatment.
Undigested compounds from red wine grape pomace reach the colon, where gut bacteria break them down into substances that strengthen the gut lining. This prevents harmful bacterial toxins from leaking into the bloodstream. With fewer toxins in the blood, immune cells do not activate as much, so they produce less of the inflammatory protein IL-1β.
What the research says
1 studyFeeding mice with heart disease a leftover part of red wine grapes lowered a harmful inflammation protein in their blood, just like a common heart medicine does.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.